Amerikanische Gesellschaft für Hirudotherapie

Autoridade Nacional Reguladora de Medicamentos — República de Moçambique

ANARME · Mozambique · africa

Regulatory jurisdiction profileJurisdictional reference
Unregulatednational regulator

Mozambique's National Medicines Regulatory Authority — leech-specific regulatory pathway has not been independently verified by ASH; medicinal leeches fall under the general national pharmaceutical and medical device framework as appropriate.

Regulatory Profile

Agency type
national regulator
Region
africa
Country
Mozambique
Leech status
unregulated
Last ASH review
2026-05-27

Relevant Regulation Codes

  • Mozambican Lei do Medicamento (Lei n.º 4/98)
  • Mozambican national medical device regulatory framework
  • Southern African Development Community (SADC) harmonised pharmaceutical frameworks where applicable
  • African Medicines Agency (AMA) harmonised frameworks (where applicable)

Prescriber Requirements

  • Ordem dos Médicos de Moçambique–registered physician — order required for any biomedical device application
  • Allied health professional application under physician supervision per institutional protocol

Supply Chain & GMP

ANARME registration as applicable; Portuguese-language labelling required by national law. Standard cold-chain conditions, with logistical constraints typical of long-coastline Southern African distribution.

Import/Export Rules

ANARME and Direcção Nacional de Serviços Veterinários clearance for live invertebrates; CITES Appendix II paperwork for Hirudo medicinalis / verbana.

Reimbursement Context

Mozambican public health system coverage depends on inpatient bundling; outpatient hirudotherapy is generally not separately reimbursed.

ASH Editorial Notes

Leech-specific pathway not independently verified by ASH; falls under general medical device / traditional medicine framework as appropriate. Southern African regulatory frameworks are progressively coordinating through SADC and the African Medicines Agency (AMA); whether this captures live-organism medical devices has not been independently mapped by ASH.

Related Jurisdictions

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.